Date	Chamber	Action
1/10/2017	Senate	Session Sine Die

Statutes Amended In Order of Appearance

225 ILCS 85/19.5 new

Synopsis As Introduced
Amends the Pharmacy Practice Act. Provides that a pharmacist may substitute a prescription biological product for a prescribed biological product only if specified criteria are met. Requires that, within a reasonable time following the dispensing of a biological product, the dispensing pharmacist or the pharmacist's designee shall communicate to the prescriber the specific product provided to the patient, including the name of the product and the manufacturer. Requires the pharmacy to retain a record of the biological product dispensed for a period of 5 years. Requires the State Board of Pharmacy to maintain a link on the Department's Internet web site to the current list of all biological products determined by the United States Food and Drug Administration to be interchangeable with a specific biological product. Effective immediately.

Actions 

Date	Chamber	Action
2/20/2015	Senate	Filed with Secretary by Sen. Antonio Muņoz
2/20/2015	Senate	First Reading
2/20/2015	Senate	Referred to Assignments
3/5/2015	Senate	Assigned to Executive
3/19/2015	Senate	Senate Committee Amendment No. 1 Filed with Secretary by Sen. Antonio Muņoz
3/19/2015	Senate	Senate Committee Amendment No. 1 Referred to Assignments
3/24/2015	Senate	Senate Committee Amendment No. 1 Assignments Refers to Executive
3/26/2015	Senate	Postponed - Executive
3/26/2015	Senate	Senate Committee Amendment No. 1 Postponed - Executive
3/27/2015	Senate	Rule 2-10 Committee Deadline Established As April 24, 2015
4/24/2015	Senate	Rule 2-10 Committee/3rd Reading Deadline Established As May 15, 2015
5/15/2015	Senate	Rule 2-10 Committee/3rd Reading Deadline Established As May 31, 2015
10/10/2015	Senate	Pursuant to Senate Rule 3-9(b) / Referred to Assignments
10/10/2015	Senate	Senate Committee Amendment No. 1 Pursuant to Senate Rule 3-9(b) / Referred to Assignments
1/10/2017	Senate	Session Sine Die

Back To Top